EMA publishes Video explaining the new Pharmacovigilance Legislation
The European Medicines Agency has produced a video with an introduction to the new pharmacovigilance legislation. Watch Dr Peter Arlett, Head of Pharmacovigilance and Risk Management, talking about the new and improved tools for regulators in Europe to ensure that patients are not exposed to unnecessary risks when taking medicines.
The new pharmacovigilance legislation came into operation on 2 July 2012. Its aim is to promote and protect public health by strengthening the existing Europe-wide system for monitoring the safety and benefit-risk balance of medicines.
Source and video
Related GMP News
16.04.2025EMA: Revised IRIS Documents
09.04.2025Centralised Procedures: Q&As Updated
12.03.2025CMDh/HMA: Guidance Documents on Variation Notifications Updated
11.03.2025EMA: Renewal of Q&A Document for "Centralized Procedures"
11.03.2025Centralised Procedures: Q&A Documents also Updated for Biosimilars
29.01.2025CMDh/HMA: Updated Guidance Documents on Variation Notifications